Skip to navigation Skip to content

Treatments of CIS


An MS disease-modifying therapy (DMT) is often recommended for people diagnosed with CIS that is considered likely to progress to clinically definite MS (CDMS), with the goal of delaying a second attack. There are DMTs approved by the US Food and Drug and Administration (FDA) for relapsing forms of MS, which includes CIS.

Early and ongoing treatment with disease-modifying therapy is supported by the MS Coalition which includes the National MS Society. This evidence-based Consensus on Disease-Modifying Therapies (.pdf) may be useful when discussing treatment options with your healthcare provider and advocating with insurers for access and coverage.


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.